Related Experiment Video
Updated: Jun 16, 2026

Whole Genome Sequencing of Candida glabrata for Detection of Markers of Antifungal Drug Resistance
Published on: December 28, 2017
Pan-azole-resistant Candida guilliermondii from a leukemia patient's silent funguria
Abstract:
Isolation of Candida non-albicans yeasts as commensals or pathogens from hospitalised hosts is acquiring increasing importance, due to the frequent drug resistance expressed by such organisms.Particularly, the recover of antifungal resistant C. guilliermondii is of worrisome concern, even if recovered as a saprophyte, since commensal yeasts may behave as reservoirs for resistance elements;furthermore, they may enter the bloodstream after chemotherapy-related mucosal damage has developed,thus causing life-threatening and difficult-to-treat fungemias. This communication deals with the unusual isolation of a pan-azole resistant C. guilliermondii strain from a leukaemic patient with silent candiduria and emphasizes the importance of monitoring less recurring species within the nosocomial setting to better understand fungal epidemiology within the wards and face the spread of resistance determinants. Also, we highlight the controversial significance of silent candiduria, clinical relevance of which should be investigated case by case, to exclude and/or prevent candiduria as well as renal impairment.
Insights
Antifungal-resistant Candida guilliermondii, even as a commensal, poses a significant threat in hospitals. Monitoring these non-albicans yeasts is crucial for understanding resistance spread and preventing difficult-to-treat infections.
Area of Science:
- Mycology
- Infectious Diseases
- Clinical Microbiology
Background:
- Non-albicans Candida species are increasingly isolated from hospitalized patients, often exhibiting drug resistance.
- Candida guilliermondii, particularly antifungal-resistant strains, is a growing concern due to its potential as a reservoir for resistance elements.
- Commensal yeasts can cause life-threatening fungemias, especially following chemotherapy-induced mucosal damage.
Observation:
- An unusual case of pan-azole resistant Candida guilliermondii was isolated from a leukemia patient.
- The patient presented with silent candiduria, highlighting the need for vigilance.
- This non-albicans yeast was isolated despite not being a primary pathogen in this instance.
Findings:
- The isolated Candida guilliermondii strain demonstrated pan-azole resistance.
- Silent candiduria was observed, posing a diagnostic challenge.
- The study underscores the importance of monitoring less common Candida species in nosocomial environments.
Implications:
- Enhanced surveillance of non-albicans yeasts is essential for understanding fungal epidemiology and combating resistance.
- The clinical significance of silent candiduria requires individual case assessment.
- Proactive monitoring can help prevent invasive candidiasis and renal complications.
Related Concept Videos
Candidiasis
Cryptococcal Meningitis
Antifungal Agents
Fungal Phylum Microsporidia
Fungal Group Zygomycota
Leishmaniasis

